News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IMRIS Reports Shareholder Vote Results At Annual Meeting


5/15/2014 6:34:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WINNIPEG
, May 14, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) has announced results of the shareholder vote at its 2014 annual general meeting held May 13, 2014 in Toronto. The Company reported that a substantial majority of the shareholders approved the following management proposals:

  • Director nominees H. David Graves, Stephen Armstrong, Carey Diamond, William Fraser, James Hickey, Blaine Hobson, and Jay D. Miller were each re-elected to IMRIS' Board of Directors. Each director received at least 98.62 percent of the vote cast "For."

  • The re-appointment of Deloitte and Touche LLP as auditors of the company, with approximately 95.78 percent of the votes cast "For."

There were no shareholder proposals put forth.

About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular, spinal and cerebrovascular markets and have been selected by 57 leading medical institutions around the world. For more information, visit www.imris.com.

SOURCE IMRIS Inc.



Help employers find you! Check out all the jobs and post your resume.
Read at BioSpace.com

comments powered by Disqus
IMRIS
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES